GlassScriptPhysician profile
Patrick Joseph Fitzgerald
NPI 1306378674
$2,686.37
in general payments reported to CMS, 2019-2025
20 companies · $844 in 2025
The $844 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $584 · 2022: $194 · 2023: $286 · 2024: $778 · 2025: $844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627 · Education: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,626.67 |
| Education | $281.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $644.26 | 2022-2025 | Avvigo Guidance System, Rotapro, Wolverine Coronary Cutting Balloon |
| Salvin Dental Specialties, INC. | $540.98 | 2021 | |
| Abbott Laboratories | $263.67 | 2024-2025 | Xience Skypoint, Coroflow, Perclose Prostyle |
| Abiomed | $262.17 | 2022-2025 | Impella |
| Medtronic, INC. | $201.17 | 2024-2025 | Onyx Frontier |
| Astrazeneca Pharmaceuticals LP | $165.15 | 2022-2025 | Brilinta, Farxiga |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Terumo Medical Corporation | $90.30 | 2022-2024 | Glidesheath Slender |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| Pfizer INC. | $66.69 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.56 | 2023-2025 | Lifevest |
| Zimmer Biomet Holdings, INC. | $26.32 | 2021 | |
| Novo Nordisk INC | $24.34 | 2023 | Ozempic |
| Philips North America LLC | $23.49 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.25 | 2023 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $20.77 | 2024 | Ensoetm |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 | |
| Zoll Circulation INC | $17.89 | 2025 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Novartis Pharmaceuticals Corporation | $14.98 | 2025 | |
| Merck Sharp & Dohme LLC | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Fitzgerald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.